Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
Published by Govt. Of India Important for pharmacy practices in India
Typology: Essays (university)
1 / 635
This page cannot be seen from the preview
Don't miss anything!
COSMETICS
1 [
2 [( aaa )] ―cosmetic‖ means any article intended to be rubbed, poured, sprinkled or sprayed on, or introduced into, or otherwise applied to, the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, and includes any article intended for use as a component
of cosmetic
3 [* * *] ;] 4 [ (b) ―drug‖ includes— 5 [ (i) all medicines for internal or external use of human beings or animals and all substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder in human beings or animals, including preparations applied on human body for the purpose of repelling insects like mosquitoes;] ( ii ) such substances (other than food) intended to affect the structure or any function of the human body or intended to be used for the destruction of
6 [vermin] or insects which cause disease in human beings or animals, as may be specified from time to time by the Central Government by notification in the Official Gazette;] 7 [ (iii) all substances intended for use as components of a drug including empty gelatin capsules; and (iv) such devices* intended for internal or external use in the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals, as may be specified from time to time by the Central Government by notification in the Official Gazette, after consultation with the Board;] 8 [ (c) ―Government Analyst‖ means— ( i ) in relation to
9 [Ayurvedic, Siddha or Unani] drug, a Government Analyst appointed by the Central Government or a State Government under section 33F; and ( ii ) in relation to any other drug or cosmetic, a Government Analyst appointed by the Central Government or a State Government under section 20;] 10 [* * * * *] 11 [ (e) ―Inspector‖ means— ( i ) in relation to
9 [Ayurvedic, Siddha or Unani] drug, an Inspector appointed by the Central Government or a State Government under section 33G; and ( ii ) in relation to any other drug or cosmetic, an Inspector appointed by the Central Government or a State Government under section 21;] 12 [
13 [ (f) ] ―manufacture‖ in relation to any drug
14 [or cosmetic] includes any process or part of a process for making, altering, ornamenting, finishing, packing, labelling, breaking up or otherwise treating or adopting any drug
14 [or cosmetic] with a view to its
15 [sale or distribution] but does not include the compounding or dispensing
16 [of any drug, or the packing of any drug or cosmetic,] in the ordinary course of retail business; and ―to manufacture‖ shall be construed accordingly;] (^17) [(g)] ―to import‖, with its grammatical variations and cognate expressions means to bring into (^18) [India];
1 [
2 [ (h) ] ―patent or proprietary medicine‖ means,—
(i) in relation to Ayurvedic, Siddha or Unani Tibb systems of medicine all formulations containing only such ingredients mentioned in the formulae described in the authoritative books of Ayurveda, Siddha or Unani Tibb systems of medicine specified in the First Schedule, but does not include a medicine which is administered by parenteral route and also a formulation included in the authoritative books as specified in clause (a) ; (ii) in relation to any other systems of medicine, a drug which is a remedy or prescription presented in a form ready for internal or external administration of human beings or animals and which is not included in the edition of the Indian Pharmacopoeia for the time being or any other Pharmacopoeia authorised in this behalf by the Central Government after consultation with the Drugs Technical Advisory Board constituted under section 5;] 3 [
2 [( i )] ―prescribed‖ means prescribed by rules made under this Act.]
4 [* * * * *] 5 [ 3A. Construction of references to any law not in force or any functionary not in existence in the State of Jammu and Kashmir. —Any reference in this Act to any law which is not in force, or any functionary not in existence, in the State of Jammu and Kashmir, shall, in relation to that State, be construed as a reference to the corresponding law in force, or to the corresponding functionary in existence, in that State.]
4. Presumption as to poisonous substances. — Any substance specified as poisonous by rule made under
Chapter III or Chapter IV
6 [or Chapter IVA] shall be deemed to be a poisonous substance for the purposes of
Chapter III or Chapter IV
6 [or Chapter IVA], as the case may be.
5. The Drugs Technical Advisory Board .— ( 1 ) The Central Government shall, as soon as may be, constitute a Board (to be called the Drugs Technical Advisory Board) to advise the Central Government and the State Governments on technical matters arising out of the administration of this Act and to carry out the other functions assigned to it by this Act. 7 [( 2 ) The Board shall consist of the following members, namely:—
( i ) the Director General of Health Services, ex officio , who shall be Chairman; ( ii ) the Drugs Controller, India, ex officio ; ( iii ) the Director of the Central Drugs Laboratory, Calcutta, ex officio ; ( iv ) the Director of the Central Research Institute, Kasauli, ex officio ; ( v ) the Director of Indian Veterinary Research Institute, Izatnagar, ex officio; ( vi ) the President of Medical Council of India, ex officio; ( vii ) the President of the Pharmacy Council of India, ex officio; ( viii ) the Director of Central Drug Research Institute, Lucknow, ex officio; ( ix ) two persons to be nominated by the Central Government from among persons who are in charge of drugs control in the States;
(e) such other matters as may be necessary or expedient to enable the said Laboratory to carry out its functions;
(f) the matters necessary to be prescribed for the purposes of the proviso to sub-section ( 1 ).
7. The Drugs Consultative Committee .—(1) The Central Government may constitute an advisory committee to be called ―the Drugs Consultative Committee‖ to advise the Central Government, the State Governments and the Drugs Technical Advisory Board on any other matter tending to secure uniformity throughout
1 [India] in the administration of this Act.
(2) The Drugs Consultative Committee shall consist of two representatives of the Central Government to be nominated by that Government and one representative of each State Government to be nominated by the State Government concerned.
(3) The Drugs Consultative Committee shall meet when required to do so by the Central Government and shall have power to regulate its own procedure. (^2) [ 7A. Sections 5 and 7 not to apply to Ayurvedic, Siddha or Unani drugs .— Nothing contained in sections 5 and 7 shall apply to 3 [Ayurvedic, Siddha or Unani] drugs.]
CHAPTER III 4 [IMPORT OF DRUGS AND COSMETICS ]
8. Standards of quality .—
5 [ (1) For the purposes of this Chapter, the expression ―standard quality‖ means— (a) in relation to a drug, that the drug complies with the standard set out in
6 [the Second Schedule], and (b) in relation to a cosmetic, that the cosmetic compiles with such standard as may be prescribed].
(2) The Central Government, after consultation with the Board and after giving by notification in the Official Gazette not less than three months‘ notice of its intention so to do, may by a like notification add to or otherwise amend
6 [the Second Schedule], for the purposes of this Chapter, and thereupon
6 [the Second Schedule] shall be deemed to be amended accordingly.
7 [ 9. Misbranded drugs. —For the purposes of this Chapter a drug shall be deemed to be misbranded—
(a) if it is so coloured, coated, powdered or polished that damage is concealed or if it is made to appear of better or greater therapeutic value than it really is; or
(b) if it is not labelled in the prescribed manner; or
(c) if its label or container or anything accompanying the drug bears any statement, design or device which makes any false claim for the drug or which is false or misleading in any particular.] 8 [ 9A. Adulterated drugs .— For the purposes of this Chapter, a drug shall be deemed to be adulterated.—
(a) if it consists, in whole or in part, of any filthy, putrid or decomposed substance; or (b) if it has been prepared, packed or stored under insanitary conditions whereby it may have been contaminated with filth or whereby it may have been rendered injurious to health; or
(c) if its container is composed in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health; or (d) if it bears or contains, for purposes of colouring only, a colour other than one which is prescribed; or (e) if it contains any harmful or toxic substance which may render it injurious to health; or (f) if any substance has been mixed therewith so as to reduce its quality or strength.
9B. Spurious drugs. — For the purposes of this Chapter, a drug shall be deemed to be spurious— (a) if it is imported under a name which belongs to another drug; or (b) if it is an imitation of, or a substitute for, another drug or resembles another drug in a manner likely to deceive or bears upon it or upon its label or container the name of another drug unless it is plainly and conspicuously marked so as to reveal its true character and its lack of identity with such other drug; or (c) if the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist; or (d) if it has been substituted wholly or in part by another drug or substance; or (e) if it purports to be the product of a manufacturer of whom it is not truly a product.
9C. Misbranded cosmetics. —For the purposes of this chapter, a cosmetic shall be deemed to be misbranded—
(a) if it contains a colour which is not prescribed; or
(b) if it is not labelled in a prescribed manner; or
(c) if the label or container or anything accompanying the cosmetic bears any statement which is false or misleading in any particular.
9D. Spurious cosmetics. —For the purposes of this Chapter, a drug shall be deemed to be spurious,—
(a) if it is imported under the name which belongs to another cosmetic; or
(b) if it is an imitation of, or is a substitute for, another cosmetic or resembles another cosmetic in a manner likely to deceive or bears upon it or upon its label or container the name of another cosmetic, unless it is plainly or conspicuously marked so as to reveal its true character and its lack of identity with such other cosmetic; or
(c) if the label or the container bears the name of an individual or company purporting to be the manufacturer of the cosmetic, which individual or company is fictitious or does not exist; or
(d) if it purports to be the product of a manufacturer of whom it is not truly a product.]
10. Prohibition of import of certain drugs or cosmetics .— From such date
1 as may be fixed by the Central Government by notification in the Official Gazette in this behalf, no person shall import—
(a) any drug
2 [or cosmetic] which is not of standard quality; (^3) [( b ) any misbranded drug 4 [or misbranded or spurious cosmetic;]
1 [Provided that consultation with the Board may be dispensed with if the Central Government is of opinion that circumstances have arisen which render it necessary to make rules without such consultation, but in such a case the Board shall be consulted within six months of the making of the rules and the Central Government shall take into consideration any suggestions which the Board may make in relation to the amendment of the said rules.]
( 2 ) Without prejudice to the generality of the forgoing power, such rules may— (a) specify the drugs or classes of drugs
2 [or cosmetics or classes of cosmetics] for the import of which a licence is required,
3 [and prescribe the form and conditions of such licences, the authority empowered to issue the same, the fees payable therefor and provide for the cancellation, or suspension of such licence in any case where any provision of this Chapter or the rules made thereunder is contravened or any of the conditions subject to which the licence is issued is not complied with]; (b) prescribe the methods of test or analysis to be employed in determining whether a drug
2 [or cosmetic] is of standard quality; (c) prescribe, in respect of biological and organometallic compounds, the units or methods of standardization; 4 [( cc ) prescribe under clause (d) of
5 [section 9A] the colour or colours which a drug may bear or contain for purposes or colouring;] (d) specify the diseases or ailments which an imported drug may not purport or claim
6 [to prevent, cure or mitigate] and such other effects which such drug may not purport or claim to have; (e) prescribe the conditions subject to which small quantities of drugs, the import of which is otherwise prohibited under this Chapter, may be imported for the purpose of examination, test or analysis or for personal use; (f) prescribe the places at which drugs
2 [or cosmetics] may be imported, and prohibit their import at any other place; (g) require the date of manufacture and the date of expiry of potency to be clearly and truly stated on the label or container of any specified imported drug or class of such drug, and prohibit the import of the said drug or class of drug after the expiry of a specified period from the date of manufacture; (h) regulate the submission by importers, and the securing, of samples of drugs
2 [or cosmetics] for examination, test or analysis by the Central Drugs Laboratory, and prescribe the fees, if any, payable for such examination, test or analysis; (i) prescribe the evidence to be supplied, whether by accompanying documents or otherwise, of the quality of drugs 2 [or cosmetics] sought to be imported, the procedure of officers of Customs in dealing with such evidence, and the manner of storage at places of import of drugs 2 [or cosmetics] detained pending admission; (j) provide for the exemption, conditionally or otherwise, from all or any of the provisions of this Chapter and the rules made thereunder of drugs
2 [or cosmetics] imported for the purpose only of transport through, an export from,
7 [India]; (k) prescribe the conditions to be observed in the packing in bottles, packages or other containers, of imported drugs 2 [or cosmetics] 8 [including the use of packing material which comes into direct contact with the drugs]; (l) regulate the mode of labeling drugs
2 [or cosmetics] imported for sale in packages, and prescribe the matters which shall or shall not be included in such labels; (m) prescribe the maximum proportion of any poisonous substance which may be added to or contained in any imported drug, prohibit the import of any drug in which that proportion is exceeded, and specify substances which shall be deemed to be poisonous for the purposes of this Chapter and the rules made thereunder;
(n) require that the accepted scientific name of any specified drug shall be displayed in the prescribed manner on the label or wrapper of any imported, patent or proprietary medicine containing such drug; (o) provide for the exemption, conditionally or otherwise, from all or any of the provisions of this Chapter or the rules made thereunder, of any specified drug or class of drugs 1 [or cosmetic or class of cosmetics]. (^2) [ 13. Offences .—( 1 ) Whoever himself or by any other person on his behalf imports, — ( a ) any drug deemed to be adulterated under section 9A or deemed to be a spurious drug under section 9B or any spurious cosmetic referred to in section 9D or any cosmetic of the nature referred to in clause (ee) of section 10 shall be punishable with imprisonment for a term which may extend to three years and a fine which may extend to five thousand rupees; ( b ) any drug or cosmetic other than a drug or cosmetic referred to in clause (a) , the import of which is prohibited under section 10, or any rule made under this Chapter, shall be punishable with imprisonment for a term which may extend to six months, or with fine which may extend to five hundred rupees, or with both; ( c ) any drug or cosmetic in contravention of the provisions of any notification issued under section 10A, shall be punishable with imprisonment for a term which may extend to three years, or with fine which may extend to five thousand rupees, or with both; ( 2 ) Whoever having been convicted of an offence— ( a ) under clause ( a ) or clause (c) of sub-section (1) , is again convicted of an offence under that clause, shall be punishable with imprisonment for a term which may extend to five years, or with fine which may extend to ten thousand rupees, or with both; (b) under clause (b) of sub-section (1) , is again convicted of an offence under that clause, shall be punishable with imprisonment for a term which may extend to one year, or with fine which may extend to one thousand rupees, or with both.
(3) The punishment provided by this section shall be in addition to any penalty to which the offender may be liable under the provisions of section 11.]
14. Confiscation. —Where any offence punishable under section 13 has been committed, the consignment of the drugs 3 [or cosmetics] in respect of which the offence has been committed shall be liable to confiscation. 15. Jurisdiction .— No Court inferior to that
4 [of a Metropolitan Magistrate or of a Judicial Magistrate of the first class] shall try an offence punishable under section 13.
CHAPTER IV
MANUFACTURE, SALE AND DISTRIBUTION OF 5 [DRUGS AND COSMETICS ]
16. Standards of quality. —
6 [ (1) For the purposes of this Chapter, the expression ―standard quality‖ means— (a) in relation to a drug, that the drug complies with the standard set out in
7 [the Second Schedule], and (b) in relation to a cosmetic, that the cosmetic complies with such standard as may be prescribed.] (2) The
8 [Central Government], after consultation with the Board and after giving by notification in the Official Gazette not less than three months‘ notice of its intention so to do, may by a like notification add to or otherwise amend
7 [the Second Schedule] for the purposes of this Chapter, and thereupon^7 [the Second Schedule] shall be deemed to be amended accordingly.
18. Prohibition of manufacture and sale of certain drugs and cosmetics .— From such date 1 as may be fixed by the State Government by notification in the Official Gazette in this behalf, no person shall himself or by any other person on his behalf—
(a)
2 [manufacture for sale or for distribution, or sell, or stock or exhibit or offer for sale] or distribute— 2 [( i ) any drug which is not of a standard quality, or is misbranded, adulterated or spurious; (^12) [( ii ) any cosmetic which is not of a standard quality or is misbranded or spurious;] 3 [( iii ) any patent or proprietary medicine, unless there is displayed in the prescribed manner on the label or container thereof
2 [the true formula or list of active ingredients contained in it together with the quantities thereof];] ( iv ) any drug which by means of any statement, design or device accompanying it or by any other means, purports or claims 4 [to prevent, cure or mitigate] any such disease or ailment, or to have any such other effect as may be prescribed; 5 [( v ) any cosmetic containing any ingredient which may render it unsafe or harmful for use under the directions indicated or recommended; ( vi ) any drug or cosmetic in contravention of any of the provisions of this Chapter or any rule made thereunder;]
( b ) 6 [sell, or stock or exhibit or offer for sale,] or distribute any drug 7 [or cosmetic] which has been imported or manufactured in contravention of any of the provisions of this Act or any rule made thereunder;
( c )
6 [manufacture for sale or for distribution, or sell, or stock or exhibit or offer for sale,] or distribute any drug
7 [or cosmetic], except under, and in accordance with the conditions of, a licence issued for such purpose under this Chapter:
Provided that nothing in this section shall apply to the manufacture, subject to prescribed conditions, of small quantities of any drug for the purpose of examination, test or analysis:
Provided further that the
8 [Central Government] may, after consultation with the Board, by notification in
the Official Gazette, permit, subject to any conditions specified in the notification, the
6 [manufacture for sale, or for distribution, sale, stocking or exhibiting or offering for sale] or distribution of any drug or class of drugs not being of standard quality.
9 [ * * * * *] 10 [18A. Disclosure of the name of the manufacturer, etc. — Every person, not being the manufacturer of a drug or cosmetic or his agent for the distribution thereof, shall, if so required, disclose to the Inspector the name, address and other particulars of the person from whom he acquired the drug or cosmetic.]
11 [18B. Maintenance of records and furnishing of information. — Every person holding a licence under clause ( c ) of section 18 shall keep and maintain such records, registers and other documents as may be prescribed and shall furnish to any officer or authority exercising any power or discharging any function under this Act such information as is required by such officer or authority for carrying out the purposes of this Act.]
19. Pleas .— ( 1 ) Save as hereinafter provided in this section, it shall be no defence in a prosecution under this Chapter to prove merely that the accused was ignorant of the nature, substance or quality of the drug 1 [or cosmetic] in respect of which the offence has been committed or of the circumstances of its manufacture or import, or that a purchaser, having bought only for the purpose of test or analysis, has not been prejudiced by the sale. (2)
2 [For the purposes of section 18 a drug shall not be deemed to be misbranded or
2 [adulterated or spurious] or to be below standard quality nor shall a cosmetic be deemed to be misbranded or to be below standard quality] only by reason of the fact that—
(a) there has been added thereto some innocuous substance or ingredient because the same is required for manufacture or preparation of the drug
1 [or cosmetic] as an article of commerce in a state fit for carriage or consumption, and not to increase the bulk, weight or measure of the drug
1 [or cosmetic] or to conceal its inferior quality or other defects; or 4 [* * * * *] (b) in the process of manufacture, preparation or conveyance some extraneous substance has unavoidably become intermixed with it: Provided that this clause shall not apply in relation to any sale or distribution of the drug 1 [or cosmetic] occurring after the vendor or distributor became aware of such intermixture. 5 [(3) A person, not being the manufacturer of a drug or cosmetic or his agent for the distribution thereof, shall not be liable for a contravention of section 18 if he proves— (a) that he acquired the drug or cosmetic from a duly licensed manufacturer, distributor or dealer thereof; (b) that he did not know and could not, with reasonable diligence, have ascertained that the drug or cosmetic in any way contravened the provisions of that section; and (c) that the drug or cosmetic, while in his possession, was properly stored and remained in the same state as when he acquired it.] 6 [20.Government Analysts .— ( 1 ) The State Government may, by notification in the Official Gazette, appoint such persons as it thinks fit, having the prescribed qualifications, to be Government Analysts for such
areas in the state and in respect of such drugs or
7 [classes of drugs or such cosmetics or classes of cosmetics] as may be specified in the notification.
(2) The Central Government may also, by notification in the Official Gazette, appoint such persons as it
thinks fit, having the prescribed qualifications, to be Government Analysts in respect of such drugs or
7 [classes of drugs or such cosmetics or classes of cosmetics] as may be specified in the notification.
(3) Notwithstanding anything contained in sub-section ( 1 ) or sub-section ( 2 ), neither the Central Government nor a State Government shall appoint as a Government Analyst any official not serving under it without the previous consent of the Government under which he is serving.
8 [ (4) No person who has any financial interest in the import, manufacture or sale of drugs or cosmetics shall be appointed to be a Government Analyst under sub-section (1) or sub-section (2) of this section.]
21. Inspectors. — ( 1 ) The Central Government or a State Government may, by notification in the Official Gazette, appoint such persons as it thinks fit, having the prescribed qualifications, to be Inspectors for such areas as may be assigned to them by the Central Government or State Government, as the case may be. ( 2 ) The powers which may be exercised by an Inspector and the duties which may be performed by him, the drugs or 9 [classes of drugs or cosmetics or classes of cosmetics] in relation to which and the conditions, limitations or restrictions subject to which, such powers and duties may be exercised or performed shall be such as may be prescribed.
(2) The provisions of
1 [the Code of Criminal Procedure, 1973 (2 of 1974)] shall, so far as may be, apply to any search or seizure under this Chapter as they apply to any search or seizure made under the
authority of a warrant issued under
1 [section 94] of the said Code. 2 [ (2A) Every record, register or other document seized under clause (cc) or produced under clause (cca) shall be returned to the person, from whom they were seized or who produce the same, within a period of twenty days of the date of such seizure or production, as the case may be, after copies thereof or extracts therefrom certified by that person, in such manner as may be prescribed, have been taken.]
( 3 ) If any person wilfully obstructs an Inspector in the exercise of the powers conferred upon him by or
under this Chapter,
2 [or refuses to produce any record, register or other document when so required under clause ( cca ) of sub- section ( 1 ),] he shall be punishable with imprisonment which may extend to three years, or with fine, or with both.]
23. Procedure of Inspectors. —( 1 ) Where an Inspector takes any sample of a drug
3 [or cosmetic] under this Chapter, he shall tender the fair price thereof and may require a written acknowledgment therefor.
( 2 ) Where the price tendered under sub-section ( 1 ) is refused, or where the Inspector seizes the stock of
any drug
3 [or cosmetic] under clause ( c ) of section 22, he shall tender a receipt therefor in the prescribed form. ( 3 ) Where an Inspector takes a sample of a drug
3 [or cosmetic] for the purpose of test or analysis, he shall intimate such purpose in writing in the prescribed form to the person from whom he takes it and, in the presence of such person unless he wilfully absents himself, shall divide the sample into four portions and effectively seal and suitably mark the same and permit such person to add his own seal and mark to all or any of the portions so sealed and marked:
Provided that where the sample is taken from premises whereon the drug
3 [or cosmetic] is being manufactured, it shall be necessary to divide the sample into three portions only:
Provided further that where the drug
3 [or cosmetic] is made up in containers of small volume, instead of
dividing a sample as aforesaid, the Inspector may, and if the drug
3 [or cosmetic] be such that it is likely to deteriorate or be otherwise damaged by exposure shall, take three or four, as the case may be, of the said containers after suitably marking the same and, where necessary, sealing them.
( 4 ) The Inspector shall restore one portion of a sample so divided or one container, as the case may be, to the person from whom he takes it, and shall retain the remainder and dispose of the same as follows: —
( i ) one portion or container he shall forthwith send to the Government Analyst for test or analysis;
( ii ) the second he shall produce to the Court before which proceedings, if any, are instituted in respect of the drug 3 [or cosmetic]; (^4) [( iii ) the third, where taken, he shall send to the person, if any, whose name, address and other particulars have been disclosed under section 18A.]
( 5 ) Where an Inspector takes any action under clause (c) of section 22, — ( a ) he shall use all despatch in ascertaining whether or not the drug
3 [or cosmetic] contravenes any of the provisions of the section 18 and, if it is ascertained that the drug
3 [or cosmetic] does not so contravene, forthwith revoke the order passed under the said clause or, as the case may be, take such action as may be necessary for the return of the stock seized; ( b ) if he seizes the stock of the drug
3 [or cosmetic], he shall as soon as may be inform
5 [a Judicial Magistrate] and take his orders as to the custody thereof; ( c ) without prejudice to the institution of any prosecution, if the alleged contravention be such that the defect may be remedied by the possessor of the drug
3 [or cosmetic], he shall, on being satisfied that the defect has been so remedied, forthwith revoke his order under the said clause.
1 [( 6 ) Where an Inspector seizes any record, register, document or any other material object under clause (cc) of sub- section (1) of section 22, he shall, as soon as may be, inform 2 [a Judicial Magistrate] and take his orders as to the custody thereof.]
24. Persons bound to disclose place where drugs or cosmetics are manufactured or kept. — Every person for the time being in charge of any premises whereon any drug 3 [or cosmetic] is being manufactured or is kept for sale or distribution shall, on being required by an Inspector so to do, be legally bound to disclose to the Inspector the place where the drug 3 [or cosmetic] is being manufactured or is kept, as the case may be. 25. Reports of Government Analysts .— ( 1 ) The Government Analyst to whom a sample of any drug
3 [or cosmetic] has been submitted for test or analysis under sub-section ( 4 ) of section 23, shall deliver to the Inspector submitting it a signed report in triplicate in the prescribed form. ( 2 ) The Inspector on receipt thereof shall deliver one copy of the report to the person from whom the sample was taken 4 [and another copy to the person, if any, whose name, address and other particulars have been disclosed under section 18A], and shall retain the third copy for use in any prosecution in respect of the sample. ( 3 ) Any document purporting to be a report signed by a Government Analyst under this Chapter shall be evidence to the facts stated therein, and such evidence shall be conclusive unless the person from whom the
sample was taken
5 [or the person whose name, address and other particulars have been disclosed under section 18A] has, within twenty-eight days of the receipt of a copy of the report, notified in writing the Inspector or the Court before which any proceedings in respect of the sample are pending that he intends to adduce evidence in controversion of the report. ( 4 ) Unless the sample has already been tested or analysed in the Central Drugs Laboratory, where a person has under sub-section (3) notified his intention of adducing evidence in controversion of a Government Analyst‘s report, the Court may, of its own motion or in its discretion at the request either of the complainant
or the accused, cause the sample of the drug
3 [or cosmetic] produced before the Magistrate under sub- section (4) of section 23 to be sent for test or analysis to the said Laboratory, which shall make the test or analysis and report in writing signed by, or under the authority of, the Director of the Central Drugs Laboratory the result thereof, and such report shall be conclusive evidence of the facts stated therein. ( 5 ) The cost of a test or analysis made by the Central Drugs Laboratory under sub-section (4) shall be paid by the complainant or accused as the Court shall direct.
26. Purchaser of drug 3 [or cosmetic] enabled to obtain test or analysis .— Any person
6 [or any recognised consumer association, whether such person is a member of that association or not,] shall, on application in the prescribed manner and on payment of the prescribed fee, be entitled to submit for test or
analysis to a Government Analyst any drug
3 [or cosmetic]
7 [purchased by him or it] and to receive a report of such test or analysis signed by the Government Analyst. 8 [ Explanation .—For the purposes of this section and section 32, ―recognised consumer association‖ means a voluntary consumer association registered under the Companies Act, 1956 (1 of 1956) or any other law for the time being in force.] 9 [26A. Power of Central Government to prohibit manufacture, etc., of drug and cosmetic in public interest .— Without prejudice to any other provision contained in this Chapter, if the Central Government is satisfied, that the use of any drug or cosmetic is likely to involve any risk to human beings or animals or that any drug does not have the therapeutic value claimed or purported to be claimed for it or contains ingredients and in such quantity for which there is no therapeutic justification and that in the public interest it is necessary or expedient so to do, then, that Government may, by notification in the Official Gazette, (^11) [regulate, restrict or prohibit] the manufacture, sale or distribution of such drug or cosmetic.] (^12) [26B. Powers of Central Government to regulate or restrict, manufacture, etc., of drug in public
interest. – Without prejudice to any other provision contained in this Chapter, if the Central Government is satisfied that a drug is essential to meet the requirements of an emergency arising due to epidemic or natural calamities and that in the public interest it is necessary or expedient so to do, then, that Government may, by notification in the Official Gazette, regulate or restrict the manufacture, sale or distribution of such drug.] 10 [ 27. Penalty for manufacture, sale, etc., of drugs in contravention of this Chapter .— Whoeve r , himself or by any other person on his behalf, manufactures for sale or for distribution, or sells, or stocks or exhibits or offers for sale or distributes, —
